Skip to content

A novel promising endometrial preparation approach for frozen-thawed embryo transfer

A novel promising endometrial preparation approach for frozen-thawed embryo transfer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041224
Enrollment
Unknown
Registered
2020-12-22
Start date
2020-12-19
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

HRT:single blastocyst transfer HRT group
DROI:single blastocyst transfer DROI group
nature cycle:NC-HRT

Sponsors

Reproductive Hospital affiliated to Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 20 to 38 years; 2. Women with regular menses (defined as spontaneous cycle length 21 to 35 days); 3. Women who undergo their first cycle of IVF or ICSI; 4. Women with the number of transferrable D3 embryos >= 4.

Exclusion criteria

Exclusion criteria: 1. Women who have been diagnosed with congenital or acquired uterine abnormalities such as uterine malformation (uterus unicornis, septate uterus or duplex uterus), adenomyosis, submucous myoma or intrauterine adhesion; 2. Women with medical conditions that contraindicate assisted reproductive technology and/or pregnancy, such as uncontrolled hypertension or known symptomatic heart disease; poorly controlled type 1 or type 2 diabetes mellitus; undiagnosed liver disease or dysfunction (based on serum liver enzyme test results); renal disease or abnormal serum renal function; severe anemia; history of deep venous thrombosis, pulmonary embolus or cerebrovascular accident; history of (or suspected) cervical carcinoma, endometrial carcinoma or breast carcinoma.

Design outcomes

Primary

MeasureTime frame
Singleton live birth rate;

Secondary

MeasureTime frame
conception rate;clinical pregnancy rate;ongoing pregnancy rate;pregnancy loss rate;live birth rate;Incidence of moderate and severe OHSS;birth weight;Incidence of ectopic preganncy;Incidence of pregnancy and perinatal complications;Incidence of neonatal complications;Incidence of other adverse events;

Countries

China

Contacts

Public ContactChao Shibin

Reproductive Hospital affiliated to Jiangxi University of Traditional Chinese Medicine

chaoshibin@163.com+86 18079111478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026